| Leighton Hugh Forrester, MD | |
|
7500 Hanover Pkwy, Suite 204, Greenbelt, MD 20770-2010 | |
| (301) 345-7878 | |
| (301) 345-4375 |
| Full Name | Leighton Hugh Forrester |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 35 Years |
| Location | 7500 Hanover Pkwy, Greenbelt, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831240191 | NPI | - | NPPES |
| 184691400 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D50913 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umd Prince George's Hospital Ctr | Cheverly, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dimensions Healthcare Associates Inc | 1557269743 | 103 |
| Capitol Cardiology Associates Pa | 6002714649 | 20 |
News Archive
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
When the respiratory illness SARS (Severe Acute Respiratory Syndrome) emerged in 2003, it killed at least 775 people before it was contained. Nine years later, MERS (Middle East Respiratory Syndrome) began circulating in the human population—and has gone on to have a 36 percent case fatality rate.
People who live in areas of California with a higher density of marijuana dispensaries experience a greater number of hospitalizations involving marijuana abuse and dependence, a University of Pittsburgh Graduate School of Public Health analysis discovered.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
The Specialty Hospital at Levindale has opened Maryland's first high intensity unit inside a chronic hospital. This unit provides heart monitoring for patients who require specialized medical care and treatment for serious illnesses and/or injuries.
› Verified 2 days ago
| Entity Name | Capitol Cardiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609855733 PECOS PAC ID: 6002714649 Enrollment ID: O20031222000112 |
News Archive
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
When the respiratory illness SARS (Severe Acute Respiratory Syndrome) emerged in 2003, it killed at least 775 people before it was contained. Nine years later, MERS (Middle East Respiratory Syndrome) began circulating in the human population—and has gone on to have a 36 percent case fatality rate.
People who live in areas of California with a higher density of marijuana dispensaries experience a greater number of hospitalizations involving marijuana abuse and dependence, a University of Pittsburgh Graduate School of Public Health analysis discovered.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
The Specialty Hospital at Levindale has opened Maryland's first high intensity unit inside a chronic hospital. This unit provides heart monitoring for patients who require specialized medical care and treatment for serious illnesses and/or injuries.
› Verified 2 days ago
| Entity Name | Dimensions Healthcare Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346354834 PECOS PAC ID: 1557269743 Enrollment ID: O20031226000032 |
News Archive
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
When the respiratory illness SARS (Severe Acute Respiratory Syndrome) emerged in 2003, it killed at least 775 people before it was contained. Nine years later, MERS (Middle East Respiratory Syndrome) began circulating in the human population—and has gone on to have a 36 percent case fatality rate.
People who live in areas of California with a higher density of marijuana dispensaries experience a greater number of hospitalizations involving marijuana abuse and dependence, a University of Pittsburgh Graduate School of Public Health analysis discovered.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
The Specialty Hospital at Levindale has opened Maryland's first high intensity unit inside a chronic hospital. This unit provides heart monitoring for patients who require specialized medical care and treatment for serious illnesses and/or injuries.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leighton Hugh Forrester, MD 7500 Hanover Pkwy, Suite 204, Greenbelt, MD 20770-2010 Ph: (301) 345-7878 | Leighton Hugh Forrester, MD 7500 Hanover Pkwy, Suite 204, Greenbelt, MD 20770-2010 Ph: (301) 345-7878 |
News Archive
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
When the respiratory illness SARS (Severe Acute Respiratory Syndrome) emerged in 2003, it killed at least 775 people before it was contained. Nine years later, MERS (Middle East Respiratory Syndrome) began circulating in the human population—and has gone on to have a 36 percent case fatality rate.
People who live in areas of California with a higher density of marijuana dispensaries experience a greater number of hospitalizations involving marijuana abuse and dependence, a University of Pittsburgh Graduate School of Public Health analysis discovered.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
The Specialty Hospital at Levindale has opened Maryland's first high intensity unit inside a chronic hospital. This unit provides heart monitoring for patients who require specialized medical care and treatment for serious illnesses and/or injuries.
› Verified 2 days ago
Michael A Schwartz, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 7500 Hanover Pkwy, Suite 204, Greenbelt, MD 20770 Phone: 301-345-7878 | |
Gaurav Lakhanpal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7300 Hanover Dr, Suite 104, Greenbelt, MD 20770 Phone: 301-486-4690 Fax: 301-486-4692 | |
Dr. Irfan Ahsan Khan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr, Suite 730, Greenbelt, MD 20770 Phone: 301-474-0400 Fax: 301-474-2686 | |
Mr. Ibrahim Jalloh, FNP Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 7500 Hanover Pkwy, Greenbelt, MD 20770 Phone: 301-441-8696 | |
Acquanetta Frazier, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8723 Greenbelt Rd Ste 201, Greenbelt, MD 20770 Phone: 301-552-9797 | |
Mushtaq Shah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7227 Hanover Pkwy Ste A, Greenbelt, MD 20770 Phone: 301-220-0606 Fax: 301-513-9049 | |
Dr. Pimolvarn Limpuangthip, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 7721 Belle Point Dr, Greenbelt, MD 20770 Phone: 301-345-1272 Fax: 301-474-2671 |